MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation

Sabit Delic, Nadine Lottmann, Anja Stelzl, Franziska Liesenberg, Marietta Wolter, Silke Götze, Marc Zapatka, Yuzuru Shiio, Michael C. Sabel, Jörg Felsberg, Guido Reifenberger, Markus J. Riemenschneider

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

BackgroundDiffusely infiltrative growth of human astrocytic gliomas is one of the major obstacles to successful tumor therapy. Thorough insights into the molecules and pathways signaling glioma cell invasion thus appear of major relevance for the development of targeted and individualized therapies. By miRNA expression profiling of microdissected human tumor biopsy specimens we identified miR-328 as one of the main miRNAs upregulated in invading glioma cells in vivo and further investigated its role in glioma pathogenesis.MethodsWe employed miRNA mimics and inhibitors to functionally characterize miR-328, 3′ untranslated region luciferase assays, and T-cell factor/lymphoid enhancer factor reporter assays to pinpoint miR-328 targets and signaling pathways, and analyzed miR-328 expression in a large panel of gliomas.ResultsFirst, we corroborated the invasion-promoting role of miR-328 in A172 and TP365MG glioma cells. Secreted Frizzled-related protein 1 (SFRP1), an inhibitor of Wnt signaling, was then pinpointed as a direct miR-328 target. SFRP1 expression is of prognostic relevance in gliomas with reduced expression, being associated with significantly lower overall patient survival in both the Repository of Molecular Brain Neoplasia Data (REMBRANDT) and The Cancer Genome Atlas. Of note, miR-328 regulated both SFRP1 protein expression levels and Wnt signaling pathway activity. Finally, in human glioma tissues miR-328 appeared to account for the downregulation of SFRP1 preferentially in lower-grade astrocytic gliomas and was inversely related to SFRP1 promoter hypermethylation.ConclusionTaken together, we report on a novel molecular miR-328-dependent mechanism that via SFRP1 inhibition and Wnt activation contributes to the infiltrative glioma phenotype at already early stages of glioma progression, with unfavorable prognostic implications for the final outcome of the disease.

Original languageEnglish (US)
Pages (from-to)179-190
Number of pages12
JournalNeuro-Oncology
Volume16
Issue number2
DOIs
StatePublished - Jan 1 2014

    Fingerprint

Keywords

  • astrocytoma
  • brain tumor
  • epigenetic
  • glioblastoma
  • miRNA

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Delic, S., Lottmann, N., Stelzl, A., Liesenberg, F., Wolter, M., Götze, S., Zapatka, M., Shiio, Y., Sabel, M. C., Felsberg, J., Reifenberger, G., & Riemenschneider, M. J. (2014). MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro-Oncology, 16(2), 179-190. https://doi.org/10.1093/neuonc/not164